Highest-materiality recent filing
Charlie's Holdings names Henry Sicignano CEO; COO Ryan Stump transitions to board role
Ryan Stump resigns as COO effective Sept 4, 2026, remains on board and will lead strategic partnerships.
Stockholders approved reverse stock split within range of 1-for-3 to 1-for-50, with board discretion to effect within two years to facilitate up-list to national exchange.
Charlie's Holdings raises $1.27M via stock sale; $1M debt forgiven, notes going concern
Sold 6.35M shares at $0.20/sh; $270K cash + $1.0M debt forgiveness.
Charlie's Holdings raises $710K via private placement of 3.55M shares at $0.20/share
Sold 3,550,000 shares of common stock at $0.20 per share to accredited investors.
Charlie's Holdings sells PACHA synthetic product to R.J. Reynolds for $1M
Sold one additional PACHA synthetic product to R.J. Reynolds Vapor for $1.0M cash at closing.
Charlie's Holdings sells three PACHA synthetic products to R.J. Reynolds for $1.5M
Amended Asset Purchase Agreement with R.J. Reynolds Vapor Company closed May 29, 2025.
Asset sale includes twelve PACHA synthetic product SKUs and related PMTA filings to R.J. Reynolds Vapor Company.
Charlie's Holdings raises $550k via 6.875M share private placement at $0.08/sh
Sold 6,875,000 common shares at $0.08 each to accredited investors, gross proceeds ~$550k.
Charlie's Holdings changes auditor; stockholders approve reverse stock split for up-listing
Audit Committee engaged Urish Popeck & Co., LLC as new independent auditor, effective June 28, 2024.
Charlie's Holdings raises ~$1.63M via sale of 20.4M shares at $0.08; discloses going concern doubt
Sold 20,375,000 shares of common stock at $0.08 per share, gross proceeds ~$1.63 million.
Charlie's Holdings auditor Mazars resigns after Q1 2024 filing; going concern noted
Mazars resigned April 17, 2024, effective after the Q1 2024 Form 10-Q filing.
Charlie's Holdings appoints Mazars USA as new auditor for FY2023
Audit Committee appointed Mazars USA LLP as independent registered public accounting firm for fiscal year ending Dec 31, 2023.
Charlie's Holdings dismisses Baker Tilly auditor; going concern note; new COO Stump
Audit committee dismissed Baker Tilly as independent auditor on June 19, 2023; Baker's 2021 and 2022 reports included going concern emphasis.
Charlie's Holdings amends Series A Preferred: adds NYSE conversion trigger, debt cap to $6M
Adds NYSE and NYSE American as exchanges that automatically convert Series A Preferred into common stock upon listing.
Charlie's Holdings CFO Matthew Montesano resigns; to serve as interim CFO until replacement
CFO Matthew P. Montesano resigned effective Feb 10, 2023, to pursue other opportunities.
Appointed Dr. Edward Carmines, Ph.D., to Board effective March 2, 2022; he is a PMTA/MRTP expert who secured FDA marketing order for 22nd Century Group.
CEO Brandon Stump resigns effective Nov 3, 2021; remains largest shareholder.
On June 15, 2023, the Company entered into a new employment agreement with Ryan Stump (the “New Agreement”). Pursuant to the New Agreement, Mr. Stump will earn a base salary of $300,000 per year and serve as Chief Operating Officer for a term of two years, renewable on an annual basis unless earlier terminated by the Company or Mr. Stump.
On February 10, 2023, Matthew P. Montesano, Chief Financial Officer of Charlie’s Holdings, Inc. (the “Company”), notified the Company that he has resigned in order to pursue other opportunities.
On March 2, 2022, Charlies Holdings, Inc. (the “ Company ”) appointed Edward Carmines, Ph.D., to the Company's Board of Directors
On October 29, 2021, David Allen resigned from his position as a member of the Board of Directors of the Company.
On October 29, 2021, Brandon Stump resigned from his position as: (i) Chief Executive Officer, Chair of the Board of Directors, and a member of the Board of Directors of Charlie’s Holdings, Inc.
On October 29, 2021, Keith Stump resigned from his position as a member of the Board of Directors of the Company.
Max materiality 0.80 · Median 0.60 · Most common event other_material